Treatment of established human graft-versus-host disease by antithymocyte globulin.
D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000628:therapy; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002648:Child; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006041:Goats / Q000276:immunology; D006086:Graft vs Host Disease / Q000188:drug therapy*; D006386:Hemagglutination Tests; D006562:Herpes Zoster / Q000150:complications; D006801:Humans; D007104:Immune Adherence Reaction; D007621:Karyotyping; D037102:Lectins / Q000494:pharmacology; D007945:Leukemia, Lymphoid / Q000628:therapy; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008251:Macaca; D008297:Male; D011020:Pneumonia, Pneumocystis / Q000150:complications; D011817:Rabbits / Q000276:immunology; D012712:Serum Globulins; D012877:Skin Manifestations; D016038:Skin Transplantation; D013950:Thymus Gland / Q000166:cytology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D037102:Lectins; D012712:Serum Globulins